Fundz

Readout, Inc. reported raising $375,000 in an initial SEC Form D filing, from an offering of $375,000

PRIVATEMar 28, 2019

Amount Raised

$375,000

$375,000 sold, per SEC Form D (first sale Mar 28, 2019)

Round Type

Seed

St. LouisHealthcare

Who else raised in Healthcare around the same time

Companies in the same sectors as Readout that raised within 45 days of this round, from Fundz verified event records.

  • Eledon raised $862K (Seed) on May 10, 2019.
  • Omeza raised $5.8M on May 10, 2019.
  • TENN-GA STONE GROUP TWO raised $16K (Pre-Seed) on May 10, 2019.
  • MBX Biosciences, Inc. raised $23M on May 10, 2019.
  • Route 92 Medical raised $13M on May 10, 2019.
  • Optimize Systems raised $425K (Seed) on May 9, 2019.

Who to call at Readout, and when

A new round usually means Readout is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Readout raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Readout, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Readout. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Readout

Location

2940 LOCUST STREET

St. Louis, Missouri, United States

About

Legal name of Biosense is Readout, Inc. Biosense has a mission to help patients better manage their own health by providing novel, clinically-backed tools to easily measure breath biomarkers. Biosense, was launched in early 2020 as a Class 1 medical device in the clinical, consumer, and research market after a successful clinical trial. As the only clinically-backed breath ketonemeasurement handheld device+app, Biosense provides full-day feedback of ketosis with unlimited measurements leading to protocol adherence and better outcomes. Biosense is used by obesity and diabetes clinics for in-home testing of ketosis, pharma and academic trials, as well as DTC.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Readout raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts6 people are listed at Readout. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Readout's next move

See what Strategic adds

Readout raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.